Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: //medlineplus.gov/ency/article/001037.htm

Rhinophyma

Rhinophyma is a large red-colored (ruddy) nose. The nose has a bulb shape.

Causes

Rhinophyma was once thought to be caused by heavy alcohol use. This is not correct. Rhinophyma occurs equally in people who do not use alcohol and in those who drink heavily. The problem is much more common in men than in women.

The cause of rhinophyma is unknown. It may be a severe form of a skin disease called rosacea. It is an uncommon disorder.

Symptoms

Symptoms include changes in the nose, such as:

  • Bulb-like (bulbous) shape
  • Many oil glands
  • Reddish color (possible)
  • Thickening of the skin
  • Waxy, yellow surface

Exams and Tests

Most of the time, a health care provider can diagnose rhinophyma without any tests. Sometimes a skin biopsy may be needed.

Treatment

The most common treatment is surgery to reshape the nose. Surgery may be done with a laser, scalpel, or rotating brush (dermabrasion). Certain acne medicines may also help treat the condition.

Outlook (Prognosis)

Rhinophyma can be corrected with surgery. The condition may return.

Possible Complications

Rhinophyma can cause emotional distress. This is because of the way it looks.

When to Contact a Medical Professional

Contact your provider if you have symptoms of rhinophyma and would like to talk about treatment.

Alternative Names

Bulbous nose; Nose - bulbous; Phymatous rosacea

Images

References

Dinulos JGH. Acne, rosacea, and related disorders. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 7.

Grande DJ. Rhinophyma. In: Lebwohl MG, Heymann WR, Coulson IH, Murrell DF, eds. Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 218.

Review Date 11/18/2022

Updated by: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Related MedlinePlus Health Topics